Literature DB >> 23039159

In vivo reflectance confocal microscopy of Basal cell carcinoma: feasibility of preoperative mapping of cancer margins.

Zhan-Yan Pan1, Jing-Ran Lin, Ting-Ting Cheng, Jia-Qiang Wu, Wen-Yu Wu.   

Abstract

BACKGROUND: Reflectance confocal microscopy (RCM) images skin at cellular resolution and has shown utility for the diagnosis of nonmelanoma skin cancer in vivo. It has the potential to define lesion margins before surgical therapy.
OBJECTIVES: To investigate the feasibility of RCM in defining the margins of basal cell carcinoma before surgery.
METHODS: The margins of 10 lesions were evaluated using RCM. Biopsies of the margins were used to confirm the results. A protocol was constructed to define margins. RCM was used to delineate preoperative surgical margins in 13 patients. Intraoperative frozen biopsy was used to confirm the margins.
RESULTS: In seven of 10 (70.0%) cases, the margins of the cancer were identified suing RCM. The tumor island was the critical feature in identifying the margins. In 12 of 13 (92.3%) cases, frozen biopsy corroborated that the surgical margins delineated by RCM were clear.
CONCLUSION: RCM imaging of the margins is feasible and demonstrates the possibility of preoperative mapping of cancer margins.
© 2012 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23039159      PMCID: PMC3546396          DOI: 10.1111/j.1524-4725.2012.02587.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


The incidence of basal cell carcinoma (BCC) is steadily increasing in most countries, accounting for approximately 80% of all nonmelanoma skin cancers. Mohs micrographic surgery (MMS) has been shown to be the most efficacious technique for removal of aggressive high-risk BCC located on the mid-face and ears,, but the technique is labor intensive and time consuming, so there is a need for effective tools for improving and facilitating accurate tumour demarcation in patients with these aggressive skin tumors. In vivo reflectance confocal microscopy (RCM) enables the noninvasive imaging of superficial layers of the skin with high resolution that provides cellular detail. RCM has previously been reported to be useful in the in vivo evaluation of skin tumors such as BCC, squamous cell carcinoma, and malignant melanoma. The ability to use RCM to perform noninvasive evaluation of skin lesions means that it has the potential to define lesion margins before surgical therapy. It has been demonstrated recently that it is possible to examine nonmelanoma skin cancers in ex vivo tissue during Mohs micrographic surgery without frozen sections. The purpose of this study was to investigate the potential of RCM to define margins of BCC before surgery.

Material and Methods

Patients

Ten patients with lesions clinically suggestive of BCC and then biopsy proven were recruited randomly from the dermatology department for the margin study. Before the biopsy, lesional and adjacent nonlesional skin was examined using RCM. Thirteen patients with biopsy-proven BCC were recruited for surgical excision. The margins of these lesions needed to be flat enough for RCM examination. This study was conducted according to the Declaration of Helsinki Principles. Institutional approval and written informed consent were obtained.

Instrumentation

Confocal imaging was performed using a commercially available near-infrared reflectance confocal laser scanning microscope (Vivascope 1500; Lucid Technologies, Henrietta, NY), which uses a diode laser with a wavelength of 830 nm and power of less than 15 mW. This system provides high-resolution images (horizontal resolution 1.0 μm, vertical optical section thickness 3.0 μm) from a depth of 0 to 250 μm in vivo (from the epidermis to the papillary dermis). A comprehensive description of this system has been reported previously.

RCM Imaging Protocol and Surgical Excision

A pilot study (the margin study) was conducted in the first 10 cases to assess qualitatively the best imaging conditions and to construct a protocol to define margins. Blocks of 2- by 2-mm mosaic image mode were used to detect the margins. Biopsies of the margins detected using RCM were performed for histopathologic analysis. Tumor islands were seen in most of the margins of the lesions,so we used this feature to delineate the margins. The final protocol was as follows (Figure 1):
Figure 1

Reflectance confocal microscopy imaging protocol and surgical excision. (A) Foci for reflectance confocal microscopy (RCM) examination were selected. (B) The lesion's border was refined (blue cross). (C) An extra 5-mm margin of normal skin was excised (dotted line). (D) The gross skin specimen was further sectioned along the boundaries inscribed using RCM. (E) RCM mosaic image of the margin. The upper half part of the image showed the normal reticulated meshwork pattern, while the lower part showed the tumor islands of elongated strands.

Reflectance confocal microscopy imaging protocol and surgical excision. (A) Foci for reflectance confocal microscopy (RCM) examination were selected. (B) The lesion's border was refined (blue cross). (C) An extra 5-mm margin of normal skin was excised (dotted line). (D) The gross skin specimen was further sectioned along the boundaries inscribed using RCM. (E) RCM mosaic image of the margin. The upper half part of the image showed the normal reticulated meshwork pattern, while the lower part showed the tumor islands of elongated strands. The lesion was evaluated by clinical inspection and palpation. The lesion's border was delineated using a Wood's lamp and dermoscopy. Selection of foci for RCM examination inside and outside the Wood's lamp and dermoscopy delineated border Refinement of the lesion's border based on RCM findings. The feature of tumor islands was the key to identify the margin. An extra 5-mm margin of normal skin was excised, and then intraoperative frozen biopsy was performed to ascertain the surgical margins. The gross skin specimen was further sectioned along the boundaries inscribed by RCM and confirmed by intraoperative frozen biopsy.

Histopathology

All biopsy specimens were routinely processed with formalin fixation and paraffin embedding followed by vertical sectioning and hematoxylin and eosin staining. Diagnoses were retrieved from the hospital information system. Slides were also examined for findings that appeared to correlate best with RCM structures under analysis.

Results

RCM Features of the Margin of the Lesions

In seven of 10 (70%) cases, the margins of the cancer were identified. The RCM mosaics of the margins showed features of lesional and normal skin (Figure 2). Five RCM features of lesional skin were seen: atypical honeycomb at the level of epidermis, tumor islands at the dermal and basal layer, elongated monomorphic nuclei, increased vascularity, and prominent inflammatory cell infiltrate. Tumor islands, which can be observed most easily at the margin of the lesions, were seen in all cases. They are characterized by aggregates of atypical cells organized into nodules, islands, cords, or elongated strands. Because the normal side of the image was characterized by ring structures or reticulated meshwork at superficial dermis, the margin was distinct (Figure 2D). Histologic examination corroborated that the surgical margins identified using RCM were correct (Figure 2E). In three of 10 (30%) cases, the margin of the lesions could not be detected because of the unevenness of the surface.
Figure 2

Reflectance confocal microscopy (RCM) images of the margin of a lesion. (A) Clinical image of a superficial basal cell carcinoma on the cheek of a 52-year-old woman. (B) RCM images of nonlesional skin showed the normal ring structures. (C) RCM images of lesional skin showed the tumor island. (D) RCM mosaic image of the margin. The left side of the image showed the tumor island, and the right side showed the normal ring structures. (E) Biopsies of the margins detected using RCM confirmed the result.

Reflectance confocal microscopy (RCM) images of the margin of a lesion. (A) Clinical image of a superficial basal cell carcinoma on the cheek of a 52-year-old woman. (B) RCM images of nonlesional skin showed the normal ring structures. (C) RCM images of lesional skin showed the tumor island. (D) RCM mosaic image of the margin. The left side of the image showed the tumor island, and the right side showed the normal ring structures. (E) Biopsies of the margins detected using RCM confirmed the result.

Surgical Excision

Thirteen patients were treated with local surgical excision. The data of the patients included are shown in Table 1. We observed nine (69.2%) BCC of the superficial type and four (30.8%) of the nodular type. Most BCC were located on the cheek. All frozen biopsies of surgical margins were negative. In 12 of 13 (92.3%) cases, frozen biopsy of RCM margins was negative. The RCM margin of a nodular type BCC case was positive. Cancer cells were found under the surface of one section.
Table 1

Clinical Data of 13 Basal Cell Carcinomas (BCC) and Histopathologic Results of Surgery

PatientBCC TypeLocationClinical Size, cmFrozen Biopsy of Surgical MarginsFrozen Biopsy of Reflectance Confocal Microscopy Margins
1SuperficialBack3.0 × 2.5NegativeNegative
2SuperficialCheek2.5 × 2.5NegativeNegative
3NodularNose0.8 × 0.8NegativeNegative
4SuperficialBack1.5 × 2.5NegativeNegative
5SuperficialCheek0.9 × 0.9NegativeNegative
6SuperficialCheek1.0 × 1.0NegativeNegative
7SuperficialLeg6.1 × 5.0NegativeNegative
8SuperficialForehead2.0 × 1.8NegativeNegative
9NodularCheek0.8 × 0.8NegativePositive
10NodularCheek1.0 × 0.5NegativeNegative
11NodularEar0.8 × 0.5NegativeNegative
12SuperficialCheek0.5 × 0.7NegativeNegative
13SuperficialNose0.8 × 0.7NegativeNegative
Clinical Data of 13 Basal Cell Carcinomas (BCC) and Histopathologic Results of Surgery

Discussion

RCM has proven to be a promising, noninvasive, high-resolution imaging tool for histologic evaluation of the skin in vivo. The major microscopic features of several premalignant and malignant skin lesions have recently been reported.– A few studies have confirmed that RCM offers a sensitive and specific tool for the noninvasive diagnosis of BCC in vivo., One potential application of RCM is to assess cancer margins. RCM may aid in the rapid establishment of tumor margins by examining excised specimens during procedures such as Mohs micrographic surgery. With RCM of ex vivo unprocessed tissues, it is possible to detect neoplastic cells using 5% acetic acid. It has also been demonstrated recently that RCM can define lesion margins, such as amelanotic melanomas and extramammary Paget disease, before surgery. We showed the feasibility of using RCM to identify the tumor margins and corroborated this finding through histologic examination of the surgical margins identified using RCM. RCM features of BCC have been previously described. With RCM, BCCs exhibit five confocal features, regardless of subtype. Our study showed that the tumor island was the critical feature in identifying the margins. The RCM mosaics of the margins showed features of lesional and normal skin. The margin of the lesions was distinct in the picture. We constructed a protocol to define the margins according to the margin study and the literature. We have presented 13 cases in which RCM was used to guide surgical excision of BCC. The current study showed that this technique can be applied in superficial and nodular types of BCC. Frozen biopsy confirmed the accuracy of the margins delineated using RCM. The present study has several limitations. The main limiting factor has been the limited depth of RCM penetration, which prevents accurate imaging at depths below the superficial dermis. The limited depth of RCM penetration accounted for the positive case of nodular type BCC. Second, this technique requires that the surface of the margin be flat enough for examination. Hyperkeratosis, the thickness, and the anatomic position of lesions may make examination difficult. Morphea-type BCC was not studied. In summary, we have demonstrated that RCM can help to delineate surgical borders in a common skin cancer: BCC. In cases involving a large area of lesional skin, margins mapped out using RCM should help Mohs micrographic surgeons in identifying surgical margins. Future studies involving larger sample sizes and histologically different BCC subtypes will be needed to further elucidate the full utility of this technique.
  17 in total

1.  Sensitivity and specificity of reflectance-mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: a multicenter study.

Authors:  Sarita Nori; Francisca Rius-Díaz; Jesus Cuevas; Mark Goldgeier; Pedro Jaen; Abel Torres; Salvador González
Journal:  J Am Acad Dermatol       Date:  2004-12       Impact factor: 11.527

2.  Detection of residual basal cell carcinoma by in vivo confocal microscopy.

Authors:  Diego E Marra; Abel Torres; Carl F Schanbacher; Salvador Gonzalez
Journal:  Dermatol Surg       Date:  2005-05       Impact factor: 3.398

3.  Confocal reflectance mosaicing of basal cell carcinomas in Mohs surgical skin excisions.

Authors:  Yogesh G Patel; Kishwer S Nehal; Iana Aranda; Yongbiao Li; Allan C Halpern; Milind Rajadhyaksha
Journal:  J Biomed Opt       Date:  2007 May-Jun       Impact factor: 3.170

4.  Clinical applicability of in vivo reflectance confocal microscopy for the diagnosis of actinic keratoses.

Authors:  Martina Ulrich; Adrienne Maltusch; Francisca Rius-Diaz; Joachim Röwert-Huber; Salvador González; Wolfram Sterry; Eggert Stockfleth; Susanne Astner
Journal:  Dermatol Surg       Date:  2008-02-08       Impact factor: 3.398

Review 5.  In vivo reflectance-mode confocal microscopy in clinical dermatology and cosmetology.

Authors:  S González; Y Gilaberte-Calzada
Journal:  Int J Cosmet Sci       Date:  2008-02       Impact factor: 2.970

6.  Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.

Authors:  Ming H Jih; Paul M Friedman; Leonard H Goldberg; Arash Kimyai-Asadi
Journal:  Dermatol Surg       Date:  2005-01       Impact factor: 3.398

7.  Confocal examination of nonmelanoma cancers in thick skin excisions to potentially guide mohs micrographic surgery without frozen histopathology.

Authors:  M Rajadhyaksha; G Menaker; T Flotte; P J Dwyer; S González
Journal:  J Invest Dermatol       Date:  2001-11       Impact factor: 8.551

Review 8.  Sunlight and cancer.

Authors:  D R English; B K Armstrong; A Kricker; C Fleming
Journal:  Cancer Causes Control       Date:  1997-05       Impact factor: 2.506

9.  Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors.

Authors:  Armin Gerger; Silvia Koller; Wolfgang Weger; Erika Richtig; Helmut Kerl; Hellmut Samonigg; Peter Krippl; Josef Smolle
Journal:  Cancer       Date:  2006-07-01       Impact factor: 6.860

10.  Investigation of basal cell carcinoma [correction of carcionoma] by confocal laser scanning microscopy in vivo.

Authors:  K Sauermann; T Gambichler; M Wilmert; S Rotterdam; M Stücker; P Altmeyer; K Hoffmann
Journal:  Skin Res Technol       Date:  2002-08       Impact factor: 2.365

View more
  16 in total

1.  Combined reflectance confocal microscopy-optical coherence tomography for delineation of basal cell carcinoma margins: an ex vivo study.

Authors:  Nicusor Iftimia; Gary Peterson; Ernest W Chang; Gopi Maguluri; William Fox; Milind Rajadhyaksha
Journal:  J Biomed Opt       Date:  2016-01       Impact factor: 3.170

2.  Peri-operative delineation of non-melanoma skin cancer margins in vivo with handheld reflectance confocal microscopy and video-mosaicking.

Authors:  E Flores; O Yélamos; M Cordova; K Kose; W Phillips; E H Lee; A Rossi; K Nehal; M Rajadhyaksha
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-03-15       Impact factor: 6.166

Review 3.  Emerging imaging technologies in dermatology: Part II: Applications and limitations.

Authors:  Samantha L Schneider; Indermeet Kohli; Iltefat H Hamzavi; M Laurin Council; Anthony M Rossi; David M Ozog
Journal:  J Am Acad Dermatol       Date:  2018-12-04       Impact factor: 11.527

4.  Intraoperative imaging during Mohs surgery with reflectance confocal microscopy: initial clinical experience.

Authors:  Eileen S Flores; Miguel Cordova; Kivanc Kose; William Phillips; Anthony Rossi; Kishwer Nehal; Milind Rajadhyaksha
Journal:  J Biomed Opt       Date:  2015-06       Impact factor: 3.170

Review 5.  Reflectance confocal microscopy of skin in vivo: From bench to bedside.

Authors:  Milind Rajadhyaksha; Ashfaq Marghoob; Anthony Rossi; Allan C Halpern; Kishwer S Nehal
Journal:  Lasers Surg Med       Date:  2016-10-27       Impact factor: 4.025

6.  Confocal imaging-guided laser ablation of basal cell carcinomas: an ex vivo study.

Authors:  Heidy Sierra; Miguel Cordova; Chih-Shan Jason Chen; Milind Rajadhyaksha
Journal:  J Invest Dermatol       Date:  2014-09-01       Impact factor: 8.551

7.  Video-mosaicing of reflectance confocal images for examination of extended areas of skin in vivo.

Authors:  K Kose; M Cordova; M Duffy; E S Flores; D H Brooks; M Rajadhyaksha
Journal:  Br J Dermatol       Date:  2014-10-26       Impact factor: 9.302

8.  High-speed combined reflectance confocal and moxifloxacin based two-photon microscopy.

Authors:  Bumju Kim; Hoan Le; Byung-Ho Oh; Ki Hean Kim
Journal:  Biomed Opt Express       Date:  2020-02-21       Impact factor: 3.732

9.  Automated registration of optical coherence tomography and dermoscopy in the assessment of sub-clinical spread in basal cell carcinoma.

Authors:  A J Coleman; G P Penney; T J Richardson; A Guyot; M J Choi; N Sheth; E Craythorne; A Robson; R Mallipeddi
Journal:  Comput Aided Surg       Date:  2014-05-01

10.  Reflectance confocal microscopy and dermoscopy for in vivo, non-invasive skin imaging of superficial basal cell carcinoma.

Authors:  Mihaela A Ghita; Constantin Caruntu; Adrian E Rosca; Harillaq Kaleshi; Ana Caruntu; Liliana Moraru; Anca Oana Docea; Sabina Zurac; Daniel Boda; Monica Neagu; Demetrios A Spandidos; Aristidis M Tsatsakis
Journal:  Oncol Lett       Date:  2016-03-21       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.